Intrexon | XON - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Amgen 19.84 5.47 2026-03
Anika Therapeutics 47.54 27.2 2024-06
AstraZeneca 29.59 2.3 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Gilead Sciences 15.63 0.08 2025-12
GlaxoSmithKline 14.87 3.72 2026-03
Incyte 15.35 0.51 2026-03
Intrexon 7.54 221.44 2021-12
Ligand Pharmaceuticals 60.65 17.62 2025-09
MannKind 303.7 273.14 2025-12
Merck 16.52 2.6 2026-03
Novartis 20.17 2.32 2026-03
Rigel Pharmaceuticals 8.61 8.4 2025-03
Roche Holding 16.09 3.51 2025-12
Thermo Fisher Scientific 27.71 3.29 2026-03
Veracyte 45.3 5.4 2025-12
Xencor 29.92 3.22 2022-09